The six compounds are: eltrombopag, used to treat thrombocytopenia; terbinadine, an antifungal drug; cornivaptan, an inhibitor of the vasopressin receptor; manidipine, an inhibitor of calcium channels; C-DIM12, a Nurr1 agonist stimulating apopotosis in bladder tumor and acting as neuroprotector in a Parkinson mouse model; and OSI-420, an inhibitor of the epithelial growth factor receptor. This evidence concerns the gene NR4A2 and urinary bladder neoplasm.